4-(2-Chlorophenyl)-5-methanesulfonyl-2-phenylpyrimidine

Catalog No. :
ACHRGV632
CAS No. :
251307-33-2
Molecular Formula :
C17H13ClN2O2S
Molecular Weight :
344.82

IUPAC Name:4-(2-chlorophenyl)-5-(methylsulfonyl)-2-phenylpyrimidine

4-(2-Chlorophenyl)-5-methanesulfonyl-2-phenylpyrimidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$323.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(2-Chlorophenyl)-5-methanesulfonyl-2-phenylpyrimidine
IUPAC Name4-(2-chlorophenyl)-5-(methylsulfonyl)-2-phenylpyrimidine
MDL No.MFCD00202709
Molecular FormulaC17H13ClN2O2S
Molecular Weight344.82
SMILESO=S(C1=CN=C(C2=CC=CC=C2)N=C1C3=CC=CC=C3Cl)(C)=O
InChI KeyWAAXXGXPFIEQSV-UHFFFAOYSA-N
Synonym4-(2-CHLOROPHENYL)-5-(METHYLSULFONYL)-2-PHENYLPYRIMIDINE;4-(2-CHLOROPHENYL)-2-PHENYL-5-PYRIMIDINYL METHYL SULFONE;4-(2-chlorophenyl)-5-methanesulfonyl-2-phenylpyrimidine;Pyrimidine, 4-(2-chlorophenyl)-5-(methylsulfonyl)-2-phenyl-
CAS No.251307-33-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACHRGV632 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACNVCU612 route compound structure diagram
    ACNVCU6123900-89-8 In Stock
  4. Then
  5. ACHRGV632 route product structure diagram
    ACHRGV632251307-33-2
Inquiry

2. ACHRGV632 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACQROT208 route compound structure diagram
    ACQROT20898-80-6 In Stock
  4. Then
  5. ACHRGV632 route product structure diagram
    ACHRGV632251307-33-2
Inquiry

Comments (0)